Cargando…

Development of a Novel Chikungunya Virus-Like Replicon Particle for Rapid Quantification and Screening of Neutralizing Antibodies and Antivirals

Chikungunya fever is a mosquito-transmitted infectious disease that induces rash, myalgia, and persistent incapacitating arthralgia. At present, no vaccines or antiviral therapies specific to Chikungunya virus (CHIKV) infection have been approved, and research is currently restricted to biosafety le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hui-Chung, Chiao, Der-Jiang, Shu, Pei-Yun, Lin, Hui-Tsu, Hsiung, Chia-Chu, Lin, Chang-Chi, Kuo, Szu-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101068/ https://www.ncbi.nlm.nih.gov/pubmed/36856407 http://dx.doi.org/10.1128/spectrum.04854-22

Ejemplares similares

Facile method for delivering chikungunya viral replicons into mosquitoes and mammalian cells
por: Lin, Hui-Chung, et al.
Publicado: (2021)

Antigenicity and immunogenicity of chikungunya virus-like particles from mosquito cells
por: Tsai, Shan-Ko, et al.
Publicado: (2022)

Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
por: Gläsker, Sabine, et al.
Publicado: (2013)

Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
por: Wang, Yu-Ming, et al.
Publicado: (2016)

High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
por: Lücke, Arlen-Celina, et al.
Publicado: (2022)

Construction of a Chikungunya Virus, Replicon, and Helper Plasmids for Transfection of Mammalian Cells
por: Colunga-Saucedo, Mayra, et al.
Publicado: (2022)

SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021)

Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021)

Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice
por: Lin, Hui-Tsu, et al.
Publicado: (2021)

Development of Neutralization Assay Using an eGFP Chikungunya Virus
por: Deng, Cheng-Lin, et al.
Publicado: (2016)

Suramin Inhibits Chikungunya Virus Entry and Transmission
por: Ho, Yi-Jung, et al.
Publicado: (2015)

A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Kotaki, Tomohiro, et al.
Publicado: (2021)

Chikungunya virus: an update on antiviral development and challenges
por: Kaur, Parveen, et al.
Publicado: (2013)

SNAP-tagged Chikungunya Virus Replicons Improve Visualisation of Non-Structural Protein 3 by Fluorescence Microscopy
por: Remenyi, Roland, et al.
Publicado: (2017)

Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
por: He, Xi, et al.
Publicado: (2021)

Antiviral Perspectives for Chikungunya Virus
por: Parashar, Deepti, et al.
Publicado: (2014)

Antivirals against the Chikungunya Virus
por: Battisti, Verena, et al.
Publicado: (2021)

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011)

Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)

Development of Zika Virus Mini-Replicon Based Single-Round Infectious Particles as Gene Delivery Vehicles
por: Wu, Joh-Sin, et al.
Publicado: (2023)

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
por: Fernandes, Rafaela S., et al.
Publicado: (2020)

Towards antivirals against chikungunya virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Antiviral Strategies Against Chikungunya Virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies
por: Ricklin, Meret E., et al.
Publicado: (2016)

Imported Chikungunya Virus Strains, Taiwan, 2006–2009
por: Huang, Jyh-Hsiung, et al.
Publicado: (2009)

Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats
por: Kamrud, Kurt I., et al.
Publicado: (2008)

Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle
por: Kamrud, K. I., et al.
Publicado: (2010)

Zika Virus Replicons for Drug Discovery
por: Xie, Xuping, et al.
Publicado: (2016)

Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs
por: Hetrick, Brian, et al.
Publicado: (2022)

The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon
por: Knudsen, Maria L., et al.
Publicado: (2013)

Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of Antivirals
por: Hao, Siyuan, et al.
Publicado: (2020)

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
por: Matsuda, Mami, et al.
Publicado: (2018)

Antivirals Against Chikungunya Virus: Is the Solution in Nature?
por: Oliveira Silva Martins, Daniel, et al.
Publicado: (2020)

Current and Promising Antivirals Against Chikungunya Virus
por: Hucke, Friederike I. L., et al.
Publicado: (2020)

A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Persistent Replication of a Chikungunya Virus Replicon in Human Cells Is Associated with Presence of Stable Cytoplasmic Granules Containing Nonstructural Protein 3
por: Remenyi, Roland, et al.
Publicado: (2018)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease
por: Bolz, Miriam, et al.
Publicado: (2015)

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery
por: Jin, Yun-Yun, et al.
Publicado: (2021)

Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Aedes Mosquitoes
por: Delang, Leen, et al.
Publicado: (2018)

Establishment of one-step SYBR green-based real time-PCR assay for rapid detection and quantification of chikungunya virus infection
por: Ho, Phui San, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_svecb3v0sqv4l6m5b77lmdj0lt